Riskpilot← Back to searchSign inGet full accessClepsydra AB
ABActiveOrg 5568200736Västergatan 6 AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20100 employees
Revenue 2025
SEK 156K
-12% vs 2024
EBITDA margin
70.5%
-17% vs 2024
Equity ratio
80.2%
Financial strength
Net profit 2025
SEK 150K
+58% vs 2024
| Revenue | SEK 156K | -12% |
| EBITDA | SEK 110K | -17% |
| Net profit | SEK 150K | +58% |
| Total assets | SEK 565K | +9% |
| Equity | SEK 453K | +50% |
| Employees | 0 | — |
Legal name
Clepsydra AB
Org number
5568200736
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
29 september 2010
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
I huvudsak utbildning, utveckling och forskning i första hand inom det medicinska biotekområdet.
Address
Västergatan 6 A
Email
pontus.nellgard@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 246 | 275 | 240 | 177 | 156 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 203 | 227 | 142 | 132 | 110 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 203 | 227 | 142 | 132 | 110 |
| Net financials | 169 | 4 | −107 | −73 | 5 |
| Profit before tax | 372 | 231 | 88 | 112 | 189 |
| Tax | −80 | −48 | −41 | −17 | −39 |
| Net profit | 292 | 183 | 47 | 95 | 150 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 515 | 537 | 435 | 516 | 565 |
| Equity | 349 | 349 | 208 | 303 | 453 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 92 | 115 | 153 | 139 | 111 |
| Total debt | 92 | 115 | 153 | 139 | 111 |
EBITDA margin
70.5%
This company
15.8%
Market median
+346% vs market
20212025
Equity ratio
80.2%
This company
38.2%
Market median
+110% vs market
20212025
Return on equity
33.1%
This company
18.4%
Market median
+80% vs market
20212025
Net profit margin
96.2%
This company
8.1%
Market median
+1088% vs market
20212025
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20212025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PK Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Clepsydra AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Kristian Raa | Audit | 0 companies |
| Pontus Olof Gustaf Nellgård | Chairman | 0 companies |
| Per Axel Gustaf Nellgård | Board of Directors | 0 companies |
| Eva Kristina B Bergström Nellgård | Deputy Board Member | 0 companies |